{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:19:41Z","timestamp":1788952781664,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224282\/Z\/21\/Z"],"award-info":[{"award-number":["224282\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Enteropathogenic\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (EPEC) and\n                    <jats:italic>Citrobacter rodentium<\/jats:italic>\n                    (CR) are extracellular enteric attaching and effacing (A\/E) pathogens of humans and mice, respectively. Their virulence relies on intimate bacterial attachment and a network of type III secretion system effectors. Here, through systematic reduction and redesign of the effector network in CR, we develop an attenuated strain, CRV (CR Vaccine), encoding a subset of ten effectors. CRV colonises C57BL\/6 mice ~100-fold lower than wild type CR (CR\n                    <jats:sub>WT<\/jats:sub>\n                    ) without causing overt pathogenesis. Moreover, C3H\/HeN mice, which succumb to CR\n                    <jats:sub>WT<\/jats:sub>\n                    infection, survive CRV challenge. Vaccination with CRV confers protection against subsequent CR\n                    <jats:sub>WT<\/jats:sub>\n                    infection in both mouse strains. Serological analysis reveals a repertoire of dominant CR antigens, including the O-antigen, the virulence factors intimin, EspA and Tir and the outer membrane proteins Lpp, OmpA, MetQ and CARC (an AIDA-like autotransporter). We show that CR\n                    <jats:sub>WT<\/jats:sub>\n                    and CRV immunisation elicits comparable B cell and antibody responses, which is contingent on intimate bacterial attachment. A corresponding EPEC strain (\n                    <jats:italic>E. coli<\/jats:italic>\n                    Vaccine, ECV) effectively colonises epithelial cells in a gut-on-chip model. These findings establish effector network minimisation as a generalisable strategy for rational bacterial\u00a0attenuation and live-attenuated vaccine design.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76138-7","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:23:25Z","timestamp":1786127005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of a live-attenuated bacterial vaccine using effector network engineering"],"prefix":"10.1038","volume":"17","author":[{"given":"Sarah","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1932-2352","authenticated-orcid":false,"given":"Priyanka","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Alberdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuza","family":"Kozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Berkachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-4613","authenticated-orcid":false,"given":"Vishwas","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Kamaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-5644","authenticated-orcid":false,"given":"Oscar","family":"Ces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-5477","authenticated-orcid":false,"given":"Jyoti","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5847-4167","authenticated-orcid":false,"given":"Julia","family":"Sanchez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2285-777X","authenticated-orcid":false,"given":"Abigail","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-1363","authenticated-orcid":false,"given":"Gad","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"76138_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2021","unstructured":"Lavelle, E. C. & Ward, R. W. Mucosal vaccines \u2014 fortifying the frontiers. Nat. Rev. Immunol. 22, 236\u2013250 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"76138_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2859-5-23","volume":"5","author":"A Detmer","year":"2006","unstructured":"Detmer, A. & Glenting, J. Live bacterial vaccines - A review and identification of potential hazards. Micro. Cell Fact. 5, 1\u201312 (2006).","journal-title":"Micro. Cell Fact."},{"key":"76138_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/imr.12968","volume":"301","author":"A Ahmed","year":"2021","unstructured":"Ahmed, A. et al. A century of BCG: Impact on tuberculosis control and beyond. Immunol. Rev. 301, 98\u2013121 (2021).","journal-title":"Immunol. Rev."},{"key":"76138_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff, K. L. et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study.  Lancet 382, 209\u2013222 (2013).","journal-title":"Lancet"},{"key":"76138_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper, J. B., Nataro, J. P. & Mobley, H. L. T. Pathogenic Escherichia coli. Nat. Rev. Microbiol 2, 123\u2013140 (2004).","journal-title":"Nat. Rev. Microbiol"},{"key":"76138_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","volume":"151","author":"MA Karmali","year":"1985","unstructured":"Karmali, M. A. et al. The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli. J. Infect. Dis. 151, 775\u2013782 (1985).","journal-title":"J. Infect. Dis."},{"key":"76138_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","volume":"140","author":"MA Karmali","year":"2010","unstructured":"Karmali, M. A., Gannon, V. & Sargeant, J. M. Verocytotoxin-producing Escherichia coli (VTEC). Vet. Microbiol. 140, 360\u2013370 (2010).","journal-title":"Vet. Microbiol"},{"key":"76138_CR8","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1128\/AAC.01783-09","volume":"54","author":"CM McGannon","year":"2010","unstructured":"McGannon, C. M., Fuller, C. A. & Weiss, A. A. Different classes of antibiotics differentially influence shiga toxin production. Antimicrob. Agents Chemother. 54, 3790\u20133798 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76138_CR9","doi-asserted-by":"publisher","first-page":"333650","DOI":"10.3389\/fmicb.2018.00440","volume":"9","author":"M Rojas-Lopez","year":"2018","unstructured":"Rojas-Lopez, M., Monterio, R., Pizza, M., Desvaux, M. & Rosini, R. Intestinal pathogenic Escherichia coli: Insights for vaccine development. Front. Microbiol. 9, 333650 (2018).","journal-title":"Front. Microbiol."},{"key":"76138_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1089\/fpd.2009.0336","volume":"6","author":"JT Fox","year":"2009","unstructured":"Fox, J. T. et al. Efficacy of Escherichia coli O157:H7 siderophore receptor\/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157. Foodborne Pathog. Dis. 6, 893\u2013899 (2009).","journal-title":"Foodborne Pathog. Dis."},{"key":"76138_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1365-2958.2011.07661.x","volume":"80","author":"ARC Wong","year":"2011","unstructured":"Wong, A. R. C. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80, 1420\u20131438 (2011).","journal-title":"Mol. Microbiol."},{"key":"76138_CR12","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1128\/iai.61.6.2486-2492.1993","volume":"61","author":"DB Schauer","year":"1993","unstructured":"Schauer, D. B. & Falkow, S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect. Immun. 61, 2486\u20132492 (1993).","journal-title":"Infect. Immun."},{"key":"76138_CR13","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1073\/pnas.92.5.1664","volume":"92","author":"TK McDaniel","year":"1995","unstructured":"McDaniel, T. K., Jarvis, K. G., Donnenberg, M. S. & Kaper, J. B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA. 92, 1664\u20131668 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76138_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0092-8674(00)80437-7","volume":"91","author":"B Kenny","year":"1997","unstructured":"Kenny, B. et al. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511\u2013520 (1997).","journal-title":"Cell"},{"key":"76138_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2958.1999.01338.x","volume":"32","author":"EL Hartland","year":"1999","unstructured":"Hartland, E. L. et al. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol. Microbiol. 32, 151\u2013158 (1999).","journal-title":"Mol. Microbiol."},{"key":"76138_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2958.2003.03329.x","volume":"47","author":"X Tu","year":"2003","unstructured":"Tu, X., Nisan, I., Yona, C., Hanski, E. & Rosenshine, I. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol. Microbiol. 47, 595\u2013606 (2003).","journal-title":"Mol. Microbiol."},{"key":"76138_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/emboj.2010.33","volume":"29","author":"N Dong","year":"2010","unstructured":"Dong, N., Liu, L. & Shao, F. A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis. EMBO J. 29, 1363\u20131376 (2010).","journal-title":"EMBO J."},{"key":"76138_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2958.2004.04308.x","volume":"54","author":"P Dean","year":"2004","unstructured":"Dean, P. & Kenny, B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54, 665\u2013675 (2004).","journal-title":"Mol. Microbiol."},{"key":"76138_CR19","doi-asserted-by":"publisher","first-page":"e1007898","DOI":"10.1371\/journal.ppat.1007898","volume":"15","author":"X Xia","year":"2019","unstructured":"Xia, X. et al. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals. PLoS Pathog. 15, e1007898 (2019).","journal-title":"PLoS Pathog."},{"key":"76138_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/emboj.2010.297","volume":"30","author":"K Baruch","year":"2011","unstructured":"Baruch, K. et al. Metalloprotease type III effectors that specifically cleave JNK and NF-\u03baB. EMBO J. 30, 221\u2013231 (2011).","journal-title":"EMBO J."},{"key":"76138_CR21","doi-asserted-by":"publisher","unstructured":"Ruano-Gallego, D. et al. Type III secretion system effectors form robust and flexible intracellular virulence networks. Science 371, https:\/\/doi.org\/10.1126\/science.abc9531 (2021).","DOI":"10.1126\/science.abc9531"},{"key":"76138_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1574-6968.2006.00481.x","volume":"265","author":"R Mundy","year":"2006","unstructured":"Mundy, R., Girard, F., Fitzgerald, A. J. & Frankel, G. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol. Lett. 265, 126\u2013132 (2006).","journal-title":"FEMS Microbiol. Lett."},{"key":"76138_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41579-019-0252-z","volume":"17","author":"C Mullineaux-Sanders","year":"2019","unstructured":"Mullineaux-Sanders, C. et al. Citrobacter rodentium\u2013host\u2013microbiota interactions: immunity, bioenergetics and metabolism. Nat. Rev. Microbiol. 17, 701\u2013715 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"76138_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.tim.2025.02.018","volume":"33","author":"S Jordan","year":"2025","unstructured":"Jordan, S., Frankel, G. & Mishra, V. Citrobacter rodentium. Trends Microbiol. 33, 1132\u20131133 (2025).","journal-title":"Trends Microbiol."},{"key":"76138_CR25","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1128\/IAI.71.6.3443-3453.2003","volume":"71","author":"BA Vallance","year":"2003","unstructured":"Vallance, B. A., Deng, W., Jacobson, K. & Finlay, B. B. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71, 3443\u20133453 (2003).","journal-title":"Infect. Immun."},{"key":"76138_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y. et al. Interleukin-22 mediates early host defence against attaching and effacing bacterial pathogens. Nat. Med. 14, 282\u2013289 (2008).","journal-title":"Nat. Med."},{"key":"76138_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1462-5822.2004.00414.x","volume":"6","author":"S Wiles","year":"2004","unstructured":"Wiles, S. et al. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol. 6, 963\u2013972 (2004).","journal-title":"Cell Microbiol."},{"key":"76138_CR28","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/nprot.2016.100","volume":"11","author":"V Crepin","year":"2016","unstructured":"Crepin, V. et al. Citrobacter rodentium mouse model of bacterial infection. Nat. Protoc. 11, 1851\u20131876 (2016).","journal-title":"Nat. Protoc."},{"key":"76138_CR29","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/IAI.72.6.3315-3324.2004","volume":"72","author":"C Maaser","year":"2004","unstructured":"Maaser, C. et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72, 3315\u20133324 (2004).","journal-title":"Infect. Immun."},{"key":"76138_CR30","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1128\/IAI.71.9.5077-5086.2003","volume":"71","author":"CP Simmons","year":"2003","unstructured":"Simmons, C. P. et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 71, 5077\u20135086 (2003).","journal-title":"Infect. Immun."},{"key":"76138_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.chom.2015.04.001","volume":"17","author":"N Kamada","year":"2015","unstructured":"Kamada, N. et al. Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe 17, 617\u2013627 (2015).","journal-title":"Cell Host Microbe"},{"key":"76138_CR32","first-page":"73","volume":"416","author":"AR Shenoy","year":"2018","unstructured":"Shenoy, A. R., Furniss, R. C. D., Goddard, P. J. & Clements, A. Modulation of host cell processes by T3SS effectors. Curr. Top. Microbiol. Immunol. 416, 73\u2013115 (2018).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"76138_CR33","doi-asserted-by":"publisher","unstructured":"Biswas, P. et al. The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes. Gut Microbes 17, https:\/\/doi.org\/10.1080\/19490976.2025.2526134 (2025).","DOI":"10.1080\/19490976.2025.2526134"},{"key":"76138_CR34","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1128\/IAI.01250-09","volume":"78","author":"R Bulgin","year":"2010","unstructured":"Bulgin, R. et al. Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect. Immun. 78, 1417\u20131425 (2010).","journal-title":"Infect. Immun."},{"key":"76138_CR35","doi-asserted-by":"publisher","first-page":"e1000683","DOI":"10.1371\/journal.ppat.1000683","volume":"5","author":"R Bulgin","year":"2009","unstructured":"Bulgin, R. et al. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog. 5, e1000683 (2009).","journal-title":"PLoS Pathog."},{"key":"76138_CR36","doi-asserted-by":"publisher","first-page":"e1005121","DOI":"10.1371\/journal.ppat.1005121","volume":"11","author":"H Yen","year":"2015","unstructured":"Yen, H., Sugimoto, N. & Tobe, T. Enteropathogenic Escherichia coli uses NleA to inhibit NLRP3 inflammasome activation. PLoS Pathog. 11, e1005121 (2015).","journal-title":"PLoS Pathog."},{"key":"76138_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.chom.2007.07.010","volume":"2","author":"J Kim","year":"2007","unstructured":"Kim, J. et al. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2, 160\u2013171 (2007).","journal-title":"Cell Host Microbe"},{"key":"76138_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature12524","volume":"501","author":"JS Pearson","year":"2013","unstructured":"Pearson, J. S. et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 501, 247\u2013251 (2013).","journal-title":"Nature"},{"key":"76138_CR39","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2019.03.028","volume":"74","author":"J Ding","year":"2019","unstructured":"Ding, J. et al. Structural and functional insights into host death domains inactivation by the bacterial arginine GlcNAcyltransferase effector. Mol. Cell 74, 922\u2013935 (2019).","journal-title":"Mol. Cell"},{"key":"76138_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1462-5822.2010.01470.x","volume":"12","author":"SR Shames","year":"2010","unstructured":"Shames, S. R. et al. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell Microbiol. 12, 1322\u20131339 (2010).","journal-title":"Cell Microbiol."},{"key":"76138_CR41","doi-asserted-by":"publisher","unstructured":"Berger, C. N. et al. EspZ of Enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation. mBio. 3, https:\/\/doi.org\/10.1128\/mbio.00317-12 (2012).","DOI":"10.1128\/mbio.00317-12"},{"key":"76138_CR42","doi-asserted-by":"publisher","first-page":"e1000743","DOI":"10.1371\/journal.ppat.1000743","volume":"6","author":"C Nadler","year":"2010","unstructured":"Nadler, C. et al. The type III secretion effector NleE inhibits NF-\u03baB activation. PLoS Pathog. 6, e1000743 (2010).","journal-title":"PLoS Pathog."},{"key":"76138_CR43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/j.1462-5822.2006.00879.x","volume":"9","author":"S Sch\u00fcller","year":"2007","unstructured":"Sch\u00fcller, S. et al. Tir phosphorylation and Nck\/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol. 9, 1352\u20131364 (2007).","journal-title":"Cell Microbiol."},{"key":"76138_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2958.2009.06938.x","volume":"75","author":"VF Crepin","year":"2010","unstructured":"Crepin, V. F. et al. Dissecting the role of the Tir:Nck and Tir:IRTKS\/IRSp53 signalling pathways in vivo. Mol. Microbiol. 75, 308\u2013323 (2010).","journal-title":"Mol. Microbiol."},{"key":"76138_CR45","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1074\/jbc.M411550200","volume":"280","author":"T Nagai","year":"2005","unstructured":"Nagai, T., Abe, A. & Sasakawa, C. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis. J. Biol. Chem. 280, 2998\u20133011 (2005).","journal-title":"J. Biol. Chem."},{"key":"76138_CR46","doi-asserted-by":"publisher","first-page":"e1000960","DOI":"10.1371\/journal.ppat.1000960","volume":"6","author":"B Wu","year":"2010","unstructured":"Wu, B. et al. NleG Type 3 efectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog. 6, e1000960 (2010).","journal-title":"PLoS Pathog."},{"key":"76138_CR47","doi-asserted-by":"publisher","unstructured":"Popov, G. et al. Distinct molecular features of NleG type 3 secreted effectors allow for different roles during Citrobacter rodentium infection in mice. Infect. Immun. 91, https:\/\/doi.org\/10.1128\/iai.00505-22 (2022).","DOI":"10.1128\/iai.00505-22"},{"key":"76138_CR48","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1128\/IAI.73.10.6283-6289.2005","volume":"73","author":"T Matsuzawa","year":"2005","unstructured":"Matsuzawa, T., Kuwae, A. & Abe, A. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect. Immun. 73, 6283\u20136289 (2005).","journal-title":"Infect. Immun."},{"key":"76138_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00062-19","volume":"10","author":"EGD Hopkins","year":"2019","unstructured":"Hopkins, E. G. D., Roumeliotis, T. I., Mullineaux-Sanders, C., Choudhary, J. S. & Frankel, G. Intestinal epithelial cells and the microbiome undergo swift reprogramming at the inception of colonic Citrobacter rodentium infection. mBio 10, 1\u201319 (2019).","journal-title":"mBio"},{"key":"76138_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.mucimm.2024.06.008","volume":"17","author":"J Sanchez-Garrido","year":"2024","unstructured":"Sanchez-Garrido, J. et al. Impaired neutrophil migration underpins host susceptibility to infectious colitis. Mucosal Immunol. 17, 939\u2013957 (2024).","journal-title":"Mucosal Immunol."},{"key":"76138_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41385-019-0235-4","volume":"13","author":"R Barry","year":"2020","unstructured":"Barry, R. et al. Faecal neutrophil elastase-antiprotease balance reflects colitis severity. Mucosal Immunol. 13, 322\u2013333 (2020).","journal-title":"Mucosal Immunol."},{"key":"76138_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13126","volume":"22","author":"D Carson","year":"2020","unstructured":"Carson, D. et al. Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease. Cell Microbiol. 22, e13126 (2020).","journal-title":"Cell Microbiol."},{"key":"76138_CR53","doi-asserted-by":"publisher","unstructured":"Sanidad, K. Z. et al. Maternal gut microbiome\u2013induced IgG regulates neonatal gut microbiome and immunity. Sci. Immunol. 7, https:\/\/doi.org\/10.1126\/sciimmunol.abh3816 (2022).","DOI":"10.1126\/sciimmunol.abh3816"},{"key":"76138_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0304-4157(75)90013-1","volume":"415","author":"V Braun","year":"1975","unstructured":"Braun, V. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim. Biophys. Acta Rev. Biomembr. 415, 335\u2013377 (1975).","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"key":"76138_CR55","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1128\/IAI.71.4.2262-2265.2003","volume":"71","author":"BC Neves","year":"2003","unstructured":"Neves, B. C., Shaw, R. K., Frankel, G. & Knutton, S. Polymorphisms within EspA filaments of enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 71, 2262\u20132265 (2003).","journal-title":"Infect. Immun."},{"key":"76138_CR56","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1128\/JCM.36.3.662-668.1998","volume":"36","author":"J Adu-Bobie","year":"1998","unstructured":"Adu-Bobie, J. et al. Detection of intimins \u03b1, \u03b2, \u03b3, and \u03b4, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol. 36, 662\u2013668 (1998).","journal-title":"J. Clin. Microbiol."},{"key":"76138_CR57","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1099\/jmm.0.010231-0","volume":"58","author":"A Arbeloa","year":"2009","unstructured":"Arbeloa, A. et al. Distribution of espM and espT among enteropathogenic and enterohaemorrhagic Escherichia coli. J. Med. Microbiol. 58, 988\u2013995 (2009).","journal-title":"J. Med. Microbiol."},{"key":"76138_CR58","doi-asserted-by":"publisher","first-page":"e1006706","DOI":"10.1371\/journal.ppat.1006706","volume":"13","author":"M Cepeda-Molero","year":"2017","unstructured":"Cepeda-Molero, M. et al. Attaching and effacing (A\/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors. PLoS Pathog. 13, e1006706 (2017).","journal-title":"PLoS Pathog."},{"key":"76138_CR59","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1074\/mcp.M111.013672","volume":"11","author":"W Deng","year":"2012","unstructured":"Deng, W. et al. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching\/effacing bacterial pathogens. Mol. Cell. Proteom. 11, 692\u2013709 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"76138_CR60","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","volume":"329","author":"MM Levine","year":"1987","unstructured":"Levine, M. M., Black, R. E., Ferreccio, C. & Germanier, R. Large-scale field trial of Ty21A live oral typhoid vaccine in enteric-coated capsule formulation.  Lancet 329, 1049\u20131052 (1987).","journal-title":"Lancet"},{"key":"76138_CR61","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","volume":"159","author":"C Ferreccio","year":"1989","unstructured":"Ferreccio, C. et al. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J. Infect. Dis. 159, 766\u2013769 (1989).","journal-title":"J. Infect. Dis."},{"key":"76138_CR62","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0264-410X(02)00410-3","volume":"21","author":"SA Khan","year":"2003","unstructured":"Khan, S. A. et al. Salmonella typhi and S. typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors. Vaccine 21, 538\u2013548 (2003).","journal-title":"Vaccine"},{"key":"76138_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","volume":"332","author":"MM Levine","year":"1988","unstructured":"Levine, M. M. et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.  Lancet 332, 467\u2013470 (1988).","journal-title":"Lancet"},{"key":"76138_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1574-6968.1993.tb06355.x","volume":"111","author":"JM Ketley","year":"1993","unstructured":"Ketley, J. M., Michalski, J., Galen, J., Levine, M. M. & Kaper, J. B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 111, 15\u201321 (1993).","journal-title":"FEMS Microbiol. Lett."},{"key":"76138_CR65","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1462-5822.2005.00656.x","volume":"8","author":"JA Guttman","year":"2006","unstructured":"Guttman, J. A. et al. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol. 8, 634\u2013645 (2006).","journal-title":"Cell Microbiol."},{"key":"76138_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.chom.2018.12.015","volume":"25","author":"G Caballero-Flores","year":"2019","unstructured":"Caballero-Flores, G. et al. Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk. Cell Host Microbe 25, 313\u2013323.e4 (2019).","journal-title":"Cell Host Microbe"},{"key":"76138_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-6148-2-22","volume":"2","author":"T Stakenborg","year":"2006","unstructured":"Stakenborg, T. et al. Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant. BMC Vet. Res. 2, 1\u201310 (2006).","journal-title":"BMC Vet. Res."},{"key":"76138_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.vetimm.2012.09.035","volume":"152","author":"S Ahmed","year":"2013","unstructured":"Ahmed, S., Byrd, W., Kumar, S. & Boedeker, E. C. A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection. Vet. Immunol. Immunopathol. 152, 146\u2013155 (2013).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"76138_CR69","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1016\/j.vaccine.2009.07.097","volume":"27","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. Vaccine 27, 5929\u20135935 (2009).","journal-title":"Vaccine"},{"key":"76138_CR70","first-page":"73","volume":"30","author":"MI Sanches","year":"2000","unstructured":"Sanches, M. I. et al. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor. J. Pediatr. Gastroenterol. Nutr. 30, 73\u201377 (2000).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"76138_CR71","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/JCM.38.7.2696-2700.2000","volume":"38","author":"A Parissi-Crivelli","year":"2000","unstructured":"Parissi-Crivelli, A., Parissi-Crivelli, J. M. & Gir\u00f3n, J. A. Recognition of Enteropathogenic Escherichia coli Virulence Determinants by Human Colostrum and Serum Antibodies. J. Clin. Microbiol. 38, 2696\u20132700 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"76138_CR72","first-page":"166","volume":"27","author":"I Loureiro","year":"1998","unstructured":"Loureiro, I. et al. Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB. J. Pediatr. Gastroenterol. Nutr. 27, 166\u2013171 (1998).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"76138_CR73","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1651-2227.1994.tb13160.x","volume":"83","author":"BT Costa Carvalho","year":"1994","unstructured":"Costa Carvalho, B. T., Bertipaglia, A., Sole, D., Naspitz, C. K. & Scaletsky, I. C. A. Detection of immunoglobulin (IgG and IgA) anti-outer-membrane proteins of enteropathogenic Escherichia coli (EPEC) in saliva, colostrum, breast milk, serum, cord blood and amniotic fluid. Study of inhibition of localized adherence of EPEC to HeLa cells. Acta Paediatr. 83, 870\u2013873 (1994).","journal-title":"Acta Paediatr."},{"key":"76138_CR74","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1128\/CVI.00027-08","volume":"15","author":"DA Vilte","year":"2008","unstructured":"Vilte, D. A., Larz\u00e1bal, M., Cataldi, \u00c1A. & Mercado, E. C. Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli. Clin. Vaccin. Immunol. 15, 1208\u20131213 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"76138_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126416","volume":"42","author":"Taha","year":"2024","unstructured":"Taha et al. Refinement and optimisation of Neisseria gonorrhoeae NHBA and MetQ vaccine candidates. Vaccine 42, 126416 (2024).","journal-title":"Vaccine"},{"key":"76138_CR76","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1128\/IAI.00898-16","volume":"85","author":"EA Semchenko","year":"2017","unstructured":"Semchenko, E. A., Day, C. J. & Seib, K. L. MetQ of Neisseria gonorrhoeae is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies. Infect. Immun. 85, 898\u2013914 (2017).","journal-title":"Infect. Immun."},{"key":"76138_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1088130","volume":"13","author":"N Yang","year":"2023","unstructured":"Yang, N. et al. Subunit vaccines for Acinetobacter baumannii. Front. Immunol. 13, 1088130 (2023).","journal-title":"Front. Immunol."},{"key":"76138_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1586\/14760584.6.1.47","volume":"6","author":"JT Poolman","year":"2007","unstructured":"Poolman, J. T. & Hallander, H. O. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev. Vaccines 6, 47\u201356 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"76138_CR79","doi-asserted-by":"crossref","unstructured":"Wong. J. L. C. et al. citrOgen: a synthesis-free polysaccharide and protein antigen-presentation to antibody-induction platform. Nat. Commun. 16, 8886 (2025).","DOI":"10.1038\/s41467-025-63922-0"},{"key":"76138_CR80","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrmicro3235","volume":"12","author":"JA Melvin","year":"2014","unstructured":"Melvin, J. A., Scheller, E. V., Miller, J. F. & Cotter, P. A. Bordetella pertussis pathogenesis: current and future challenges. Nat. Rev. Microbiol. 12, 274\u2013288 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"76138_CR81","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.chom.2021.08.012","volume":"29","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. Systematic reconstruction of an effector-gene network reveals determinants of Salmonella cellular and tissue tropism. Cell Host Microbe 29, 1531\u20131544 (2021).","journal-title":"Cell Host Microbe"},{"key":"76138_CR82","doi-asserted-by":"crossref","unstructured":"Joshua, P. M. et al. Salmonella multimutants enable efficient identification of SPI-2 effector protein function in gut inflammation and systemic colonization. Nat. Commun. 16, 9795 (2025).","DOI":"10.1038\/s41467-025-64760-w"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76138-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:03:38Z","timestamp":1788951818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76138"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76138-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9629"}}